BVS Implantation in Patients With Variant Angina and MODerate Coronary Artery Disease: Pilot Study
Who is this study for? Patients with variant angina and moderate coronary artery disease
What treatments are being studied? BVS+OMT
Status: Withdrawn
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Phase 4
SUMMARY
The purpose of this study is to determine whether BVS(Bioresorbable Vascular Scaffold) implantation with optimal medical therapy can improve the outcome of patients with variant angina and moderate coronary artery disease.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 19
Healthy Volunteers: f
View:
• Age 19 and more
• Vasospastic angina diagnosed by provocation test including ergonovine provocation coronary angiography or ergonovine echocardiogram
• No-ischemia producing moderate coronary artery disease(stenosis\>50%, FFR\>0.8)
Locations
Other Locations
Republic of Korea
Asan Medical Center
Seoul
Time Frame
Start Date: 2017-04-19
Completion Date: 2017-04-19
Treatments
Experimental: BVS and OMT
Optimal medical treatment + BVS implantation
Related Therapeutic Areas
Sponsors
Leads: Seung-Jung Park
Collaborators: CardioVascular Research Foundation, Korea